These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 7218764

  • 21. Anaemia in dermatitis herpetiformis. The role of dapsone-induced haemolysis and malabsorption.
    Cream JJ, Scott GL.
    Br J Dermatol; 1970 Apr; 82(4):333-42. PubMed ID: 5441766
    [No Abstract] [Full Text] [Related]

  • 22. [Dapsone-induced photodermatitis in a patient with leprosy].
    Fumey SM.
    Z Hautkr; 1988 Jan 18; 63(1):53-4. PubMed ID: 3354248
    [Abstract] [Full Text] [Related]

  • 23. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES, Huikeshoven H, Zuidema J, Leiker DL, Merkus FW.
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb 18; 20(2):51-6. PubMed ID: 7061179
    [Abstract] [Full Text] [Related]

  • 24. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A, Balakrishnan S.
    Lepr India; 1982 Oct 18; 54(4):664-70. PubMed ID: 7183832
    [Abstract] [Full Text] [Related]

  • 25. Peripheral neuropathy and haemolytic anaemia with cherry red spot on macula in dapsone poisoning.
    Abhayambika K, Chacko A, Mahadevan K, Najeeb OM.
    J Assoc Physicians India; 1990 Aug 18; 38(8):564-5. PubMed ID: 2174032
    [Abstract] [Full Text] [Related]

  • 26. Incidence and patterns of hemolytic anemia in acute dapsone overdose.
    Cha YS, Kim H, Kim J, Kim OH, Kim HI, Cha K, Lee KH, Hwang SO.
    Am J Emerg Med; 2016 Mar 18; 34(3):366-9. PubMed ID: 26830387
    [Abstract] [Full Text] [Related]

  • 27. Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.
    Wertheim MS, Males JJ, Cook SD, Tole DM.
    Br J Ophthalmol; 2006 Apr 18; 90(4):516. PubMed ID: 16547343
    [No Abstract] [Full Text] [Related]

  • 28. Deformities in leprosy patients attending urban leprosy clinic at Varanasi.
    Kaur P, Singh G.
    Indian J Lepr; 1985 Apr 18; 57(1):178-82. PubMed ID: 3839818
    [Abstract] [Full Text] [Related]

  • 29. High dose dapsone toxicity.
    Shelley WB, Goldwein MI.
    Br J Dermatol; 1976 Jul 18; 95(1):79-82. PubMed ID: 952745
    [Abstract] [Full Text] [Related]

  • 30. Dapsone dependent nodular panniculitis.
    Uplekar MW, Antia NH.
    Indian J Lepr; 1986 Jul 18; 58(2):286-90. PubMed ID: 3805799
    [Abstract] [Full Text] [Related]

  • 31. Association between regularity in dapsone (DDS) treatment and development of deformity.
    Radhakrishna S, Nair NG.
    Int J Lepr Other Mycobact Dis; 1987 Sep 18; 55(3):425-34. PubMed ID: 3655458
    [Abstract] [Full Text] [Related]

  • 32. Utilization of medical agencies and treatment compliance by urban (Madras) leprosy patients.
    Kumar A, Sivaprasad N, Anbalagan M, Thangavel N, Durgambal K.
    Lepr India; 1983 Apr 18; 55(2):322-32. PubMed ID: 6632787
    [Abstract] [Full Text] [Related]

  • 33. Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in Taiwan.
    Sheen YS, Chu CY, Wang SH, Tsai TF.
    J Dermatolog Treat; 2009 Apr 18; 20(6):340-3. PubMed ID: 19954390
    [Abstract] [Full Text] [Related]

  • 34. Protective effect of fluoroquinolones on dapsone induced erythrolysis.
    Chatterjee N, Mehta VL, Tayal G.
    Indian J Exp Biol; 1995 Nov 18; 33(11):883-5. PubMed ID: 8786165
    [Abstract] [Full Text] [Related]

  • 35. Acne fulminans with dapsone induced haemolysis: a case report.
    Ismail R.
    Med J Malaysia; 1987 Jun 18; 42(2):124-6. PubMed ID: 2971861
    [No Abstract] [Full Text] [Related]

  • 36. Factors influencing the level of dapsone in blood.
    Beiguelman B, Pinto W, El-Guindy MM, Krieger H.
    Bull World Health Organ; 1974 Jun 18; 51(5):467-71. PubMed ID: 4549497
    [Abstract] [Full Text] [Related]

  • 37. Drug resistance in Nepali leprosy patients.
    Butlin CR, Neupane KD, Failbus SS, Morgan A, Britton WJ.
    Int J Lepr Other Mycobact Dis; 1996 Jun 18; 64(2):136-41. PubMed ID: 8690972
    [Abstract] [Full Text] [Related]

  • 38. Haematological alterations in leprosy patients treated with dapsone.
    Halim NK, Ogbeide E.
    East Afr Med J; 2002 Feb 18; 79(2):100-2. PubMed ID: 12380888
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of aspirin and chloramphenicol in normal and leprotic patients before and after dapsone therapy.
    Garg SK, Kumar B, Shukla VK, Bakaya V, Lal R, Kaur S.
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr 18; 26(4):204-5. PubMed ID: 3403099
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of secondary dapsone resistance in Gudiyattam Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 1. Preliminary report.
    Balraj V, Jesudasan K, Chacko CJ, Christian M, Taylor PM, Fritschi EP, Job CK.
    Int J Lepr Other Mycobact Dis; 1980 Dec 18; 48(4):397-401. PubMed ID: 7193654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.